Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Equity Ratio
69.98%
Quarterly · Period ending:
BIO Equity Ratio
Latest reported69.98%period ending
Latest reported69.98%period ending
BIO Quarterly Equity Ratio (41.82% → 69.98%)
Latest values, visible window
High-resolution chart · PNG
BIO equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 69.9756% | |
| 69.9826% | |
| 70.4732% | |
| 69.4773% | |
| 69.7927% | |
| 70.1109% | |
| 70.1541% | |
| 70.617% | |
| 69.9677% | |
| 71.778% | |
| 71.0715% | |
| 70.7485% | |
| 70.5187% | |
| 71.4379% | |
| 71.2153% | |
| 70.1052% | |
| 70.3557% | |
| 70.8441% | |
| 76.886% | |
| 76.841% | |
| 76.6981% | |
| 76.1425% | |
| 76.16% | |
| 73.4148% | |
| 72.8254% | |
| 72.4645% | |
| 71.8586% | |
| 71.4938% | |
| 71.7517% | |
| 70.8716% | |
| 71.65% | |
| 72.9383% | |
| 72.6399% | |
| 72.2149% | |
| 68.5757% | |
| 68.0514% | |
| 67.8418% | |
| 68.4954% | |
| 66.9824% | |
| 67.2357% | |
| 67.4789% | |
| 67.7903% | |
| 67.1346% | |
| 66.2702% | |
| 66.9126% | |
| 66.0969% | |
| 65.3988% | |
| 64.2857% | |
| 64.8819% | |
| 64.8753% | |
| 64.5281% | |
| 64.7554% | |
| 59.4616% | |
| 58.76% | |
| 58.5161% | |
| 58.5792% | |
| 58.4396% | |
| 57.7077% | |
| 56.3141% | |
| 57.0123% | |
| 56.6917% | |
| 55.4286% | |
| 50.1735% | |
| 53.0844% | |
| 50.8535% | |
| 50.3436% | |
| 49.6766% | |
| 48.7716% | |
| 47.3534% | |
| 52.5039% | |
| 51.1048% | |
| 52.1223% | |
| 53.1015% | |
| 52.709% | |
| 49.2845% | |
| 55.2612% | |
| 54.1957% | |
| 53.5558% | |
| 51.3441% | |
| 51.5045% | |
| 50.6088% | |
| 49.6651% | |
| 46.1224% | |
| 45.5092% | |
| 45.1426% | |
| 44.6265% | |
| 43.5171% | |
| 50.7007% | |
| 53.2403% | |
| 51.9588% | |
| 49.9505% | |
| 49.6216% | |
| 57.8555% | |
| 55.9922% | |
| 53.1546% | |
| 49.5847% | |
| 48.4168% | |
| 44.4021% | |
| 41.5008% | |
| 39.7839% |